Daiwa Securities Group Inc. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$112,000
+600.0%
1,315
+10.5%
0.00%
Q2 2020$16,0000.0%1,1900.0%0.00%
Q1 2020$16,000
-30.4%
1,190
+9.1%
0.00%
Q4 2019$23,000
+43.8%
1,091
-10.1%
0.00%
Q3 2019$16,000
-5.9%
1,2140.0%0.00%
Q2 2019$17,000
-26.1%
1,2140.0%0.00%
Q1 2019$23,000
+21.1%
1,214
-9.4%
0.00%
Q4 2018$19,000
+11.8%
1,340
+59.5%
0.00%
Q3 2018$17,000
-15.0%
8400.0%0.00%
Q2 2018$20,000
+66.7%
8400.0%0.00%
Q1 2018$12,0008400.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders